HealthCare Global Enterprises (HCG) has entered into a Deed of Admission and Retirement of Partner with Apex Criticare LLP (Apex Criticare), Niruja Product Development and Healthcare Research (Niruja) and Apex HCG Oncology Hospitals LLP (the LLP), on August 01, 2018, with respect to the retirement/exit of Apex Criticare as a partner in the LLP, and the consequent induction of Niruja as a new partner in the LLP.
On and from the execution date, Apex Criticare has exited from the LLP as a partner. The partners of the LLP from the Execution Date are HCG and Niruja, with a capital contribution in the ratio of 99.9% and 0.1%, respectively.
HCG is the largest provider of cancer care in India. Through its network of comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 6694.40 |
Max Healthcare Inst | 1039.35 |
Narayana Hrudayalay | 1287.85 |
Aster DM Healthcare | 489.85 |
Global Health | 1023.35 |
View more.. |